Skip to main content

BRIEF RESEARCH REPORT article

Front. Pharmacol.
Sec. Obstetric and Pediatric Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1370797

ANTIHYPERTENSIVE THERAPY DURING PREGNANCY: THE PRESCRIPTION PATTERN IN ITALY

Provisionally accepted
Anna Locatelli Anna Locatelli 1,2*Nicolò Bellante Nicolò Bellante 2Gianluca Donatiello Gianluca Donatiello 2Filomena Fortinguerra Filomena Fortinguerra 3Valeria Belleudi Valeria Belleudi 4Francesca Romana Poggi Francesca Romana Poggi 4Serena Perna Serena Perna 4Francesco Trotta Francesco Trotta 3
  • 1 IRCCS San Gerardo dei Tintori Foundation, Monza, Italy
  • 2 Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
  • 3 Italian Medicines Agency (AIFA), Rome, Lazio, Italy
  • 4 Departement of Epidemiology, Regional Health Service of Lazio, Rome, Lazio, Italy

The final, formatted version of the article will be published soon.

    Drug use during pregnancy should be evidence-based and favor the safest and most appropriate prescription. The Italian Medicines Agency coordinates a network focusing on monitoring medication use in pregnancy. Hypertensive disorders are common medical complication of pregnancy and antihypertensive therapy is prescribed to reduce the risk of adverse feto-maternal complications. The objective of this study is to highlight the prescription pattern of antihypertensive drugs before pregnancy, during pregnancy and in the postpartum period in Italy and to evaluate their use with a specific attention to the prescription pattern of drugs considered safe during pregnancy. A multi-database cross-sectional population study using a Common Data Model was performed. We selected all women aged 15-49 years living in eight Italian regions who gave birth in hospital between April 1, 2016 and March 31, 2018. In a cohort of 449.012 women, corresponding to 59% of Italian deliveries occurred in the study period, the prevalence of prescription of antihypertensive drugs in the preconceptional period was 1.2 %, in pregnancy 2.0 % and in the postpartum period 2.9 %. Beta-blockers were the most prescribed drugs before pregnancy (0.28-0.30%). Calcium channel blockers were the most prescribed drugs during pregnancy, with a prevalence of 0.23%, 0.33%, 0.75% in each trimester. Alfa-2-adrenergic receptor agonists were the second most prescribed during pregnancy with a prevalence of 0.16%, 0.26% and 0.55% respectively. The prescription of drugs contraindicated during pregnancy was below 0.5%. In general, the prescription of antihypertensive drugs in the Italian Mom-Network is coherent with the drugs compatible with pregnancy.

    Keywords: Hypertension, Pregnancy, Antihypertensives, Preeclampsia, Prescription pattern

    Received: 15 Jan 2024; Accepted: 12 Aug 2024.

    Copyright: © 2024 Locatelli, Bellante, Donatiello, Fortinguerra, Belleudi, Poggi, Perna and Trotta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Anna Locatelli, IRCCS San Gerardo dei Tintori Foundation, Monza, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.